Financing, Equity Capital Markets

CymaBay Therapeutics, Inc.

01/23
|
$97.7 Million
Piper Sandler served as left bookrunner for Cymabay Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma